![Marc Dunoyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Dunoyer
Amministratore Delegato presso
ALEXION PHARMACEUTICALS, INC.
Profilo
Marc Pierre Jean Dunoyer è Chief Financial Officer & Executive Director di AstraZeneca Plc e fa parte del consiglio di amministrazione di altre 5 società. In precedenza ha occupato la posizione di Global Head-Rare Diseases Unit presso GlaxoSmithKline Plc e Presidente di GlaxoSmithKline KK (una filiale di GlaxoSmithKline Plc) e Presidente-Asia Pacific presso Hoechst Marion Roussel SA. Ha ricevuto un MBA da Hautes Etudes Commerciales e una laurea all'Universit de Paris IV Paris-Sorbonne.
Ultime notizie su Marc Dunoyer
Posizioni attive di Marc Dunoyer
| Società | Posizione | Inizio |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/08/2021 |
| ALEXION PHARMACEUTICALS, INC. | Amministratore Delegato | - |
| CELLECTIS S.A. | Direttore/Membro del Consiglio | 06/05/2024 |
| JCR PHARMACEUTICALS CO., LTD. | Direttore/Membro del Consiglio | 01/06/2023 |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Direttore/Membro del Consiglio | 29/11/2013 |
Alexion Pharmaceuticals, Inc. /New/ | Amministratore Delegato | 01/08/2021 |
AstraZeneca KK
 AstraZeneca KK Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medical drugs | Presidente | - |
Astrazeneca Intermediate Holdings Ltd.
 Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as an intermediate holding company through its subsidiaries researches, manufactures and markets pharmaceuticals | Direttore/Membro del Consiglio | - |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Direttore/Membro del Consiglio | 07/06/2018 |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Precedenti posizioni note di Marc Dunoyer
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Marc Dunoyer
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
66
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Hoechst Marion Roussel SA
 Hoechst Marion Roussel SA Pharmaceuticals: OtherHealth Technology Medicinal chemicals and botanical products | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
GlaxoSmithKline KK
 GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables Researches, develops, imports, manufactures and sells toiletry products | Consumer Non-Durables |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
JCR Pharmaceuticals Co., Ltd.
 JCR Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells ethical drugs and regenerative medicine | Health Technology |
Hautes Etudes Commerciales
 Hautes Etudes Commerciales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Commercial Services |
AstraZeneca KK
AstraZeneca KK Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medical drugs | Health Technology |
Astrazeneca Intermediate Holdings Ltd.
Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as an intermediate holding company through its subsidiaries researches, manufactures and markets pharmaceuticals | Health Technology |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Alexion Pharmaceuticals, Inc. /New/ | |
Paris University of
 Paris University of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
